SymBio Pharmaceuticals Limited enterprise value

The Enterprise Value as of November 2026 (TTM) for SymBio Pharmaceuticals Limited (SYMQY) is 2.92B

According to SymBio Pharmaceuticals Limited’s latest financial reports and current stock price. The company's current Enterprise Value is 2.92B. This represents a change of -43.41% compared to the average of 5.15B of the last 4 quarters.

SymBio Pharmaceuticals Limited (SYMQY) Historical Enterprise Value (quarterly & annually)

How has SYMQY Enterprise Value performed in the past?

The mean historical Enterprise Value of SymBio Pharmaceuticals Limited over the last ten years is 10.97B. The current 2.92B Enterprise Value has changed -73.42% with respect to the historical average. Over the past ten years (40 quarters), SYMQY's Enterprise Value was at its highest in in the June 2021 quarter at 89.20B. The Enterprise Value was at its lowest in in the June 2024 quarter at 1.03B.

SymBio Pharmaceuticals Limited (SYMQY) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of SymBio Pharmaceuticals Limited Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

SymBio Pharmaceuticals Limited (SYMQY) Average Enterprise Value

How has SYMQY Enterprise Value performed in the past?

The current Enterprise Value of SymBio Pharmaceuticals Limited (SYMQY) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

SymBio Pharmaceuticals Limited (SYMQY) Enterprise Value vs. Peers

How is SYMQY’s Enterprise Value compared to its peers?

SymBio Pharmaceuticals Limited’s Enterprise Value is greater than Syros Pharmaceuticals, Inc. (-77440267.00), greater than Oncolytics Biotech Inc. (54.04M), greater than Allarity Therapeutics, Inc. (19.62M), greater than Kairos Pharma, Ltd. (-814820.00), greater than Cerenome, Inc. (11.07M), greater than LianMedical (-5151943.00), greater than Actuate Therapeutics Inc (4.15M), greater than Citius Oncology, Inc. (53.15M), greater than CNS Pharmaceuticals, Inc. (-13393860.00), less than Veraxa Biotech Holding AG (0),

Build a custom stock screener for SymBio Pharmaceuticals Limited (SYMQY) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like SymBio Pharmaceuticals Limited using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

SymBio Pharmaceuticals Limited (SYMQY) and other stocks custom spreadsheet templates

The easiest way to analyze a company like SymBio Pharmaceuticals Limited or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.